| Page 1186 | Kisaco Research
 

Osmaan Shah

Founder & CEO
Formulate

Osmaan is the founder and CEO of Formulate, a customization manufacturing platform and consumer brand that offers personalized hair, scalp, and skin care products.

Osmaan Shah

Founder & CEO
Formulate

Osmaan Shah

Founder & CEO
Formulate

Osmaan is the founder and CEO of Formulate, a customization manufacturing platform and consumer brand that offers personalized hair, scalp, and skin care products.

 

Tomasz Rygiel

Co-founder & Member of the Board
Cellis

Tomasz Rygiel

Co-founder & Member of the Board
Cellis

Tomasz Rygiel

Co-founder & Member of the Board
Cellis
 

Kiran Sonaje

Head, R&D
Advamedica

Kiran Sonaje

Head, R&D
Advamedica

Kiran Sonaje

Head, R&D
Advamedica
 

Mariann Micsinai-Balan

Vice President, Head of Data Science and Statistical Methodology
Bristol Myers Squibb

Mariann Micsinai-Balan

Vice President, Head of Data Science and Statistical Methodology
Bristol Myers Squibb

Mariann Micsinai-Balan

Vice President, Head of Data Science and Statistical Methodology
Bristol Myers Squibb
 

Fia Navntoft

Senior Clinical Project Manager
Mölnlycke Healthcare

Fia Navntoft

Senior Clinical Project Manager
Mölnlycke Healthcare

Fia Navntoft

Senior Clinical Project Manager
Mölnlycke Healthcare
 

Leo Mavely

Founder and Chief Executive Officer
AXIO Biosolutions

Leo Mavely is the CEO of Axio Biosolutions a medtech company focused on novel

biomaterials for advanced wound care and surgical solutions. Axiostat® its flagship product

which was developed to reduce the mortality due to traumatic bleeding from life threatening

injuries and is approved in over 45 countries and used by major armed forces globally. Their

more recent offering, Maxiocel is a 100% chitosan based advanced woundcare platform that

is CE marked and now used across Europe.

Leo Mavely

Founder and Chief Executive Officer
AXIO Biosolutions

Leo Mavely

Founder and Chief Executive Officer
AXIO Biosolutions

Leo Mavely is the CEO of Axio Biosolutions a medtech company focused on novel

biomaterials for advanced wound care and surgical solutions. Axiostat® its flagship product

which was developed to reduce the mortality due to traumatic bleeding from life threatening

injuries and is approved in over 45 countries and used by major armed forces globally. Their

more recent offering, Maxiocel is a 100% chitosan based advanced woundcare platform that

is CE marked and now used across Europe.

A bioengineer by qualification, Leo invented the core technology of Axio and is passionate

about building affordable healthcare products. Leo holds multiple patents and publications in

the field of novel biomaterials for medical tech applications.

Leo was featured in the list of 40 under 40 emerging business leaders by Fortune Magazine

consecutively in 2016, 2017, 2018 and 2019 and in the list of 35 under 35 entrepreneurs by

Entrepreneur magazine in 2020. He was the recipient of Silicon valley challenge 2014,

Anjani Mashelkar Inclusive Innovation Award 2013, CNBC Samsung Social Innovation

Award 2012 and was invited speaker at Indian Science congress 2010.

Axio has raised over $20mn in venture funding from Accel Partners, Ratan Tata’s UC-RNT

Fund, Omidyar network, Chiratate venture and TrueScale capital. Axio has its state of the art

R&D and manufacturing facility in India and is head quartered in Cambridge, USA.

 

Aaron Morales

Head of ESG - UK, Iberia & LatAm
S & P Global

Aaron Morales

Head of ESG - UK, Iberia & LatAm
S & P Global

Aaron Morales

Head of ESG - UK, Iberia & LatAm
S & P Global
 

Mallikarjun Choudhary

Executive Director
MSCI

Mallikarjun Choudhary

Executive Director
MSCI

Mallikarjun Choudhary

Executive Director
MSCI
iPSC Sample Attendee List
Sample Attendee List